News publications
Jane ja Aatos Erkon säätiö myönsi lähes 10 miljoonaa euroa avustuksia
Tampereen yliopiston uutiset (2.10.2025)
Tampere University licenses to Theravia a drug molecule intended for rare and severe skin disorders
Tampere University news (19.2.2025)
Tampere University, Theravia Partner to Advance New EB Drug
A new drug screening method could bring a solution to drug delivery and efficacy issues
Wound-homing molecule accelerates tissue repair
DecoDerma granted rare pediatric disease (RPD) designation for rare disease epidermolysis bullosa by the FDA
Tampere University news (10.11.2023)
DecoDerma granted orphan-drug designation for rare disease epidermolysis bullosa by FDA
Tampere University news (2.2.2023)